Data Hide ‘Critical Disparities’ in Nasopharyngeal Carcinoma Incidence Among Asian Americans
The incidence was highest among Laotian and Chinese Americans.
Head and Neck Cancer
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
Reductions in oropharynx cancer incidence should be seen among young and middle-aged adults.
No Survival Benefit With Nivolumab Plus Ipilimumab in R/M Head and Neck Squamous Cell Carcinoma
The phase 3 CheckMate 651 trial showed prolonged overall survival and durable responses in specific subsets of patients.
Avelumab Doesn’t Improve Upon Standard Care for Head and Neck Cancer
Avelumab plus cetuximab and radiotherapy did not improve progression-free survival over standard care in cisplatin-fit or -unfit patients.
Gemcitabine Plus Cisplatin Improves Overall Survival in Advanced Nasopharyngeal Carcinoma
Gemcitabine plus cisplatin reduced the risk of death by 28%.
Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
New Therapies on the Horizon for Elderly or Frail Patients With Head and Neck Cancer
A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.
Sodium Thiosulfate Appears to Decrease Ototoxic Effects of Platinum Chemo Without Compromising Efficacy
More studies are needed to confirm if there is an effect on survival, according to researchers.
Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors
Response endpoints were not strongly correlated with overall survival at the trial level.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...